Trials / Conditions / Bacterial Infection Due to Helicobacter Pylori (H. Pylori)

Bacterial Infection Due to Helicobacter Pylori (H. Pylori)

13 registered clinical trials studyying Bacterial Infection Due to Helicobacter Pylori (H. Pylori) — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Unknown	Reinfection After Eradication of Helicobacter Pylori Infection NCT02674802	The First Affiliated Hospital of Nanchang University	—
Unknown	High Dose Dual Therapy (HDDT) for Eradication of Helicobacter Pylori Infection NCT02553083	Rabin Medical Center	Phase 4
Completed	Bleeding Ulcer and Erosions Study "BLUE Study" NCT03367897	Ostfold Hospital Trust	—
Completed	Epidemiology of Helicobacter Pylori Infection Among Shanghai Children NCT02160860	Children's Hospital of Fudan University	—
Completed	Rifaximin Associated With Classic Triple Therapy for the Eradication of Helicobacter Pylori Infection NCT03124199	Fundación de Investigación Biomédica - Hospital Universitario de La Princesa	Phase 3
Recruiting	Changes Associated With H. Pylori and Gastric Carcinogenesis NCT02164409	Weill Medical College of Cornell University	—
Completed	POCone-UBiT-IR300 Pediatric Comparison Study NCT01623154	Otsuka America Pharmaceutical	Phase 4
Completed	Helicobacter Eradication Aspirin Trial NCT01506986	University of Nottingham	Phase 4
Completed	RCT: Triple vs Sequential vs Concomitant Therapy H Pylori NCT02092506	Changi General Hospital	Phase 4
Completed	The Impact of Helicobacter Pylori Infection on Immune Regulation and Clinical Course in HIV Patients in Ghana NCT01897909	Bernhard Nocht Institute for Tropical Medicine	—
Unknown	Increased Re-eradication Rate of Helicobacter Pylori by Adding N-acetylcystein or Metronidazole to the Triple NCT01572597	Buddhist Tzu Chi General Hospital	Phase 4
Completed	Resistance of Helicobacter Pylori to Antibiotics in Children NCT01902589	HaEmek Medical Center, Israel	—
Completed	Helicobacter Pylori and the Long-term Risk of Peptic Ulcer Bleeding NCT01591486	Chinese University of Hong Kong	—